QUOTED. 24 March 2021. Michael Gold.
Executive Summary
Results from a Medtronic-sponsored clinical trial of cardiac resynchronization therapy suggest pacemakers and defibrillators may be underutilized, said Michael Gold, a cardiologist at the Medical University of South Carolina, Charleston.
“We're depriving patients of therapy that may be lifesaving or may keep them from getting worse heart failure because we think that we shouldn't put [a device] in unless their heart function is going to return to normal. But that’s not what we do with medications or what we do in other therapies … We’d like them to get better … but if we can keep them from getting worse, that's [also] a good outcome.” – Michael Gold, cardiologist, Medical University of South Carolina, Charleston
Click here for a free trial of Medtech Insight